Synergistic Antiproliferative Effects of EGCG and Myricetin on Cervical Cancer Biomarkers in ME180 and SiHa Cell Lines
More in vitro and cell- and patient-derived xenograft models studies are needed to support the synergistic effect of EGCG and myricetin.
Authors
- Runjun D. Kumar (ORCID: https://orcid.org/0000-0001-7369-5956)
- Arunachalam Chinnathambi (ORCID: https://orcid.org/0000-0001-5075-5901)
- S Rangaraj
- Chaiyavat Chaiyasut (ORCID: https://orcid.org/0000-0002-1633-2419)
- Palanisamy Arulselvan
- Muruganantham Bharathi (ORCID: https://orcid.org/0000-0003-3235-5837)
- Sridhar Muthusami (ORCID: https://orcid.org/0000-0002-3595-9081)
- Tahani Awad Alahmadi (ORCID: https://orcid.org/0000-0001-9842-8205)
- Kaviyaprabha Rangaraj
- Miji Thandaserry Vasudevan
Institutions
- King Saud University (SA)
- King Khalid University Hospital (SA)
- Chiang Mai University (TH)
- Karpagam Academy of Higher Education (IN)
- Saveetha University (IN)
Publication Details
- Journal
- Current Gene Therapy
- Published
- 2025-09-18
- DOI
- https://doi.org/10.2174/0115665232363374250901071820
- Citations
- 2
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 2.94